(Reuters) – Europe’s drug regulator said on Friday South Korean drugmaker Celltrion’s COVID-19 treatment can be considered for patients at high risk of severe illness,
Read more
Home »
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. An independent data monitoring committee is recommending stopping enrollment of a
Read more
NEW YORK (Reuters Health) – Long-term glucocorticoid (GC) users see greater gains in spine bone-mineral density when treated with the monoclonal antibody denosumab versus oral
Read more
NEW YORK (Reuters Health) – Following steroid withdrawal, the anti-CD20 monoclonal antibody rituximab is effective in maintaining long-term remission of steroid-dependent nephrotic syndrome (SDNS) while
Read more
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BAVENCIO® This medicine is subject to additional monitoring. This will allow quick
Read more